Lattulosio Almus (Lactulose)

Lactulose reaches the colon unchanged, where intestinal bacteria ferment it into short‑chain fatty acids. This fermentation creates an osmotic gradient that pulls water into the bowel, promoting laxation. The resulting acidic environment also traps ammonia as ammonium, decreasing its absorption and helping control hepatic encephalopathy.

The dose of lactulose is individualized by the prescribing clinician based on the patient’s condition, severity, and response. The prescriber determines the appropriate amount and frequency, and adjustments are made according to clinical effect and tolerability.

Safety data for lactulose in pregnancy and lactation are limited. It is generally categorized as a drug with unknown risk, and the decision to use it should be made by a healthcare professional after weighing potential benefits against possible risks to the mother and infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactulose is an osmotic laxative, differing from stimulant laxatives that act on intestinal nerves. It provides a gentler, water‑based softening effect and also lowers ammonia levels, a benefit not shared by most other laxatives. Its dual action makes it especially useful in patients with liver disease.

Store the product at room temperature, below 25 °C, in its original packaging. Protect it from moisture and direct sunlight to maintain stability. No special refrigeration is required for this oral formulation.

Lattulosio Almus is taken orally, usually as a liquid or solution, according to the prescriber’s instructions. It can be measured with a calibrated device and may be mixed with a small amount of water or juice to improve palatability.

Serious concerns include severe electrolyte disturbances, marked dehydration, and rare allergic reactions such as rash or angioedema. In patients with advanced liver disease, monitoring for hepatic decompensation is advisable.

Lactulose should be avoided in individuals with known or suspected intestinal obstruction, perforation, or severe inflammatory bowel disease. Patients with hypersensitivity to lactulose or its excipients should also refrain from using the product.